APSR2026-75

 
Late-Breaking
Submitted
Poster Presentation
 
AP14-002
P21
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1199738-46904-APSR壁报1_432740.pdf
Format: PDF Only
08. Lung Cancer
2

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

yaqun liu * The First Affiliated Hospital of Hebei North University Department of Respiratory and Critical Care Medicine zhangjiakou China
jianhua liu - The First Affiliated Hospital of Hebei North University Department of Respiratory and Critical Care Medicine zhangjiakou China
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
yaqun
liu
842742960@qq.com
+8615324389347
31-40
China
Original Research
Expression and clinical significance of circular RNA circSATB2 and MMP-9 in serum of non-small cell lung cancer
Maximum 25 words
Abstract Content
Lung cancer is the leading cause of cancer-related deaths globally. Recent studies indicate that in 2025, over 1 million new lung cancer cases and more than 730,000 deaths were reported in China. To improve the survival rate of lung cancer patients, standardized and systematic diagnosis and staging are essential, along with the formulation of multidisciplinary treatment regimens in clinical practice, which is crucial for prolonging patients’ survival and optimizing their prognosis. 肺癌是全球癌症相关死亡的主要原因。最新研究显示,2025年中国报告了超过100万例新肺癌病例和超过73万例死亡。为了提高肺癌患者的生存率,标准化且系统化的诊断和分期至关重要,同时临床实践中制定多学科治疗方案,这对于延长患者生存和优化预后至关重要。肺癌是全球癌症相关死亡的首要原因。近期研究表明,到2025年,中国报告的新发肺癌病例超过100万例,死亡人数超过73万。为提高肺癌患者的生存率,标准化和系统的诊断与分期至关重要,同时在临床实践中制定多学科联合治疗方案,对于延长患者生存期、优化预后具有重要意义。Lung cancer is the leading cause of cancer-related deaths globally. Recent studies indicate that in 2025, over 1 million new lung cancer cases and more than 730,000 deaths were reported in China. To improve the survival rate of lung cancer patients, standardized and systematic diagnosis and staging are essential, along with the formulation of multidisciplinary treatment regimens in clinical practice, which is crucial for prolonging patients’ survival and optimizing their prognosis. 肺癌是全球癌症相关死亡的主要原因。最新研究显示,2025年中国报告了超过100万例新肺癌病例和超过73万例死亡。为了提高肺癌患者的生存率,标准化且系统化的诊断和分期至关重要,同时临床实践中制定多学科治疗方案,这对于延长患者生存和优化预后至关重要。肺癌是全球癌症相关死亡的首要原因。近期研究表明,到2025年,中国报告的新发肺癌病例超过100万例,死亡人数超过73万。为提高肺癌患者的生存率,标准化和系统的诊断与分期至关重要,同时在临床实践中制定多学科联合治疗方案,对于延长患者生存期、优化预后具有重要意义。
Real-time fluorescence quantitative polyribonucleotide chain reaction (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA) were used to detect the expression level of circSATB2 and the content of MMP-9 in serum of each group and analyze the relationship between the two and the clinicopathological characteristics of the patients. The diagnostic value of circSATB2 and MMP-9 for lung cancer was assessed by a subject's work characteristic curve (ROC). 采用实时荧光定量多核糖核苷酸链反应(qRT-PCR)和酶联免疫吸附测定(ELISA)检测各组血清中 circSATB2 表达水平和 MMP-9 含量,并分析两者与患者临床病理特征的关系。通过受试者的工作特征曲线(ROC)评估了 circSATB2 和 MMP-9 在肺癌中的诊断价值。采用实时荧光定量多聚核苷酸链式反应(qRT-PCR)和酶联免疫吸附试验(ELISA)检测各组血清中circSATB2的表达水平及MMP-9含量,并分析二者与患者临床病理特征之间的关系。通过受试者工作特征曲线(ROC)评估circSATB2和MMP-9在肺癌诊断中的价值。采用实时荧光定量多核糖核苷酸链式反应(qRT-PCR)和酶联免疫吸附测定(ELISA)检测各组血清中circSATB2的表达水平及MMP-9含量,并分析两者与患者临床病理特征的关系。通过受试者工作特征曲线(ROC)评估circSATB2和MMP-9在肺癌诊断中的价值。
The relative expression level of circSATB2 and the content of MMP-9 in serum of patients with lung cancer were higher than those in normal control group, and the difference was statistically significant. The expression of circSATB2 and the content of MMP-9 in serum of patients with lung cancer was correlated with TNM staging, degree of differentiation, lymph node metastasis and carcinoembryonic antigen. Combined detection of the two yielded the largest area under the ROC curve and the highest diagnostic efficacy. 肺癌患者血清中 circSATB2 的相对表达水平和 MMP-9 含量高于正常对照组,且差异具有统计学显著性。肺癌患者血清中 circSATB2 的表达和 MMP-9 含量与 TNM 分期、分化程度、淋巴结转移及癌胚抗原相关。两者结合检测获得了 ROC 曲线下最大的区域和最高的诊断效果。肺癌患者的血清中circSATB2的相对表达水平和MMP-9含量均高于正常对照组,且差异具有统计学意义。肺癌患者血清中circSATB2的表达水平和MMP-9含量与TNM分期、分化程度、淋巴结转移以及癌胚抗原(CEA)呈相关性。两者联合检测可获得最大的ROC曲线下面积,诊断效果最高。肺癌患者血清中circSATB2的相对表达水平和MMP-9含量均高于正常对照组,且差异具有统计学显著性。circSATB2的表达和MMP-9含量与TNM分期、分化程度、淋巴结转移及癌胚抗原(CEA)呈相关性。两者联合检测可获得ROC曲线下面积最大、诊断效果最佳的结果。
The relative expression of circSATB2 and the content of MMP-9 increased in serum of patients with lung cancer, and the two were related to the increment, invasion and migration of tumors. The combined detection of circSATB2 and MMP-9 provides important clinical reference significance for illness judgment and early lung cancer diagnosis. circSATB2 的相对表达和 MMP-9 含量在肺癌患者血清中增加,且两者与肿瘤的增大、侵袭和迁移有关。环性 SATB2 和 MMP-9 的联合检测为疾病判断和早期肺癌诊断提供了重要的临床参考意义。肺癌患者的血清中circSATB2的相对表达水平和MMP-9含量均升高,且两者与肿瘤的增殖、浸润和转移密切相关。同时检测circSATB2和MMP-9可为疾病判断及早期肺癌诊断提供重要的临床参考价值。肺癌患者血清中circSATB2的相对表达和MMP-9含量均升高,且两者与肿瘤的增大、浸润和转移密切相关。环状SATB2与MMP-9的联合检测为疾病判断及早期肺癌诊断提供了重要的临床参考意义。肺癌患者血清中circSATB2的相对表达水平和MMP-9含量均显著升高,二者与肿瘤的增殖、浸润和转移密切相关。同时检测circSATB2和MMP-9可为疾病判断及早期肺癌诊断提供重要的临床参考价值。
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Special AT-rich sequence binding protein 2,Matrix metalloprotein-9, Clinicopathological characteristics;
maximum 3 keywords and no abbreviations, separated by commas
 
408